Tocqueville Asset Management L.P. lifted its holdings in shares of Becton Dickinson and Co (NYSE:BDX) by 1.0% in the 3rd quarter, HoldingsChannel reports. The fund owned 22,151 shares of the medical instruments supplier’s stock after purchasing an additional 215 shares during the period. Tocqueville Asset Management L.P.’s holdings in Becton Dickinson and were worth $5,782,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Acropolis Investment Management LLC bought a new stake in shares of Becton Dickinson and during the third quarter worth about $101,000. Truvestments Capital LLC bought a new stake in shares of Becton Dickinson and during the third quarter worth about $105,000. Almanack Investment Partners LLC. bought a new stake in shares of Becton Dickinson and during the second quarter worth about $105,000. Bridgeworth LLC bought a new stake in shares of Becton Dickinson and during the second quarter worth about $131,000. Finally, Sageworth Trust Co bought a new stake in shares of Becton Dickinson and during the third quarter worth about $147,000. 85.19% of the stock is owned by institutional investors.

Shares of BDX stock opened at $234.44 on Friday. Becton Dickinson and Co has a 52-week low of $209.91 and a 52-week high of $265.87. The company has a quick ratio of 0.69, a current ratio of 1.03 and a debt-to-equity ratio of 0.90. The stock has a market capitalization of $64.71 billion, a price-to-earnings ratio of 21.29, a PEG ratio of 1.67 and a beta of 1.21.

Becton Dickinson and (NYSE:BDX) last issued its quarterly earnings data on Tuesday, November 6th. The medical instruments supplier reported $2.93 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $2.93. Becton Dickinson and had a net margin of 1.47% and a return on equity of 13.88%. The business had revenue of $4.40 billion during the quarter, compared to the consensus estimate of $4.36 billion. During the same period in the prior year, the firm posted $2.40 EPS. The firm’s quarterly revenue was up 39.0% compared to the same quarter last year. On average, equities analysts expect that Becton Dickinson and Co will post 12.1 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 31st. Shareholders of record on Monday, December 10th will be given a $0.77 dividend. This represents a $3.08 dividend on an annualized basis and a yield of 1.31%. This is an increase from Becton Dickinson and’s previous quarterly dividend of $0.75. The ex-dividend date is Friday, December 7th. Becton Dickinson and’s dividend payout ratio is presently 27.25%.

Several research firms have recently commented on BDX. Deutsche Bank began coverage on shares of Becton Dickinson and in a research report on Thursday. They set a “buy” rating and a $280.00 target price for the company. UBS Group began coverage on shares of Becton Dickinson and in a research report on Tuesday, November 27th. They set a “neutral” rating and a $260.00 target price for the company. Citigroup decreased their target price on shares of Becton Dickinson and from $289.00 to $279.00 and set a “buy” rating for the company in a research report on Tuesday, November 13th. KeyCorp upped their price objective on shares of Becton Dickinson and from $264.00 to $273.00 and gave the stock an “overweight” rating in a research report on Thursday, November 8th. Finally, Barclays set a $260.00 price objective on shares of Becton Dickinson and and gave the stock a “hold” rating in a research report on Thursday, November 8th. Six analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Becton Dickinson and has a consensus rating of “Buy” and a consensus price target of $255.53.

In other Becton Dickinson and news, SVP Charles R. Bodner sold 2,080 shares of the business’s stock in a transaction dated Friday, November 16th. The shares were sold at an average price of $245.83, for a total value of $511,326.40. Following the transaction, the senior vice president now directly owns 4,497 shares in the company, valued at $1,105,497.51. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP James W. Borzi sold 5,887 shares of the business’s stock in a transaction dated Friday, November 30th. The shares were sold at an average price of $252.37, for a total transaction of $1,485,702.19. Following the completion of the transaction, the executive vice president now owns 6,013 shares in the company, valued at $1,517,500.81. The disclosure for this sale can be found here. Insiders sold a total of 81,795 shares of company stock valued at $19,571,318 over the last ninety days. 1.00% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION NOTICE: This news story was published by Watch List News and is the property of of Watch List News. If you are viewing this news story on another website, it was illegally copied and republished in violation of U.S. & international copyright & trademark laws. The original version of this news story can be read at https://www.watchlistnews.com/tocqueville-asset-management-l-p-acquires-215-shares-of-becton-dickinson-and-co-bdx/2670951.html.

Becton Dickinson and Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral IV and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, IV fluids, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps and dedicated disposables, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems.

Recommended Story: Buyback For Investors Defined

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton Dickinson and Co (NYSE:BDX).

Institutional Ownership by Quarter for Becton Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.